The global oligonucleotide and peptide therapeutic market is experiencing rapid growth due to the constant development of new technologies, emerging markets and novel drug classes. Stay at the forefront of global investments, deals and developments in the oligonucleotide and peptide market by attending IBC's 18th Annual TIDES meeting, held May 9-12, 2016 in Long Beach, California.
1. The Oligo Therapeutics Market Landscape – A 15 Year Retrospective on Market Trends, Deals, Investments, and Key Clinical Developments with a Look to the Future Gary Carter, Director of Strategy and Marketing, Nucleic Acid Solutions Division, Agilent Technologies, Inc. Over the last 15 years the number of oligo therapeutic programs has grown from roughly 100 programs in 2002 to almost 300 in 2015, driven by the emergence of new classes such as siRNA, miRNA, and exon-skipping therapeutics, coupled with corresponding increases in direct investment and deal values. Read full abstract here.
2. Redefining the Therapeutic Peptide Business in the 21st Century Rodney Lax, Ph.D., Business Consultant, PolyPeptide Group The last 30 years has seen significant changes in our expectations for peptide therapeutics. While the peptide manufacturing industry has consolidated during that period, the complexity of the products themselves, the scale of manufacture, and number of potential delivery platforms have continually increased...(read full abstract here )
3. Personalized Medicine Patent Law Update Laura A. Labeots, Ph.D., J.D., Partner, Husch Blackwell Brief summary of Subject Matter Eligibility of patents based on natural products (35 USC 101) will be presented, along with discussion of practical implications of developing case law surrounding personalized medicine and nucleic acid diagnostics and therapeutics...(read full abstract here)
• 800+ attendees representing 25 countries help you forge new business and scientific collaborations;
• 100+ speaker presentations across 5 tracks provide a customized agenda of solutions for your company’s current challenges;
• 70+ exhibitors demonstrate the latest products and technologies to accelerate your therapeutic to market;
• 40+ poster presentations keep you abreast of cutting-edge industry and academic research
For full program details, download the TIDES 2016 brochure today!
Register by January 29 and Receive a $600 Savings! Use unique code B16180LINK100.
Best,
The TIDES 2016 Team
Visit the website.
Follow us on Twitter: @ibcusa #ibcTIDES
Read our blog: www.futurebiopharma.blogspot.com
Industry Experts Provide Updates on the Oligonucleotide and Peptide Market and Investment Landscape:
1. The Oligo Therapeutics Market Landscape – A 15 Year Retrospective on Market Trends, Deals, Investments, and Key Clinical Developments with a Look to the Future Gary Carter, Director of Strategy and Marketing, Nucleic Acid Solutions Division, Agilent Technologies, Inc. Over the last 15 years the number of oligo therapeutic programs has grown from roughly 100 programs in 2002 to almost 300 in 2015, driven by the emergence of new classes such as siRNA, miRNA, and exon-skipping therapeutics, coupled with corresponding increases in direct investment and deal values. Read full abstract here.
2. Redefining the Therapeutic Peptide Business in the 21st Century Rodney Lax, Ph.D., Business Consultant, PolyPeptide Group The last 30 years has seen significant changes in our expectations for peptide therapeutics. While the peptide manufacturing industry has consolidated during that period, the complexity of the products themselves, the scale of manufacture, and number of potential delivery platforms have continually increased...(read full abstract here )
3. Personalized Medicine Patent Law Update Laura A. Labeots, Ph.D., J.D., Partner, Husch Blackwell Brief summary of Subject Matter Eligibility of patents based on natural products (35 USC 101) will be presented, along with discussion of practical implications of developing case law surrounding personalized medicine and nucleic acid diagnostics and therapeutics...(read full abstract here)
The #1 Meeting for Oligos and Peptides!
• 100+ speaker presentations across 5 tracks provide a customized agenda of solutions for your company’s current challenges;
• 70+ exhibitors demonstrate the latest products and technologies to accelerate your therapeutic to market;
• 40+ poster presentations keep you abreast of cutting-edge industry and academic research
For full program details, download the TIDES 2016 brochure today!
Register by January 29 and Receive a $600 Savings! Use unique code B16180LINK100.
Best,
The TIDES 2016 Team
Visit the website.
Follow us on Twitter: @ibcusa #ibcTIDES
Read our blog: www.futurebiopharma.blogspot.com
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment